ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 4170 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 4170; 2) Community: the network communities that were significantly associated with the response to NSC 4170; 3) Molecule: the relationships between components within communities and NSC 4170; 4) MDR: the compounds that were significantly associated with the NSC 4170.

NSC Compound Enrichment Correlation
NSC 237020 TA 1067 0.0102077332082017 0.093266998
NSC 339638 2H-Pyran-2-one, 5,6-dihydro-6-[3,6,13-trihydroxy-3-methyl- 4-(phosphonooxy)-1,7,9,11-tridecatetraenyl]-, monosodiumsalt 0.0102077332082017 0.26356962
NSC 100880 Camptothecin 0.0112341530780141 -0.015352315
NSC 119915 3-(4,5,6-trihydroxy-3-oxo-3H-xanthen-9-yl)propanoic acid 0.0112341530780141 0.23840638
NSC 244404 Null 0.0112341530780141 0.053506197
NSC 254665 JUSTICIDIN B 0.0112341530780141 0.049410599
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.0112341530780141 0.13432803
NSC 359239 Antibiotic X-14766A 0.0112341530780141 0.066514562
NSC 40618 Cyclohexanone, 2,6-dibenzylidene- (8CI) 0.0112341530780141 0.11560147
NSC 619030 Analog of CC-1065 0.0112341530780142 0.1072889
Total:62  Current:14    [First] [Prev] [Next] [Last]